Bridgeway Capital Management’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,680
| Closed | -$90.2K | – | 1270 |
|
|
2024
Q1 | $90.2K | Hold |
3,680
| – | – | ﹤0.01% | 1215 |
|
|
2023
Q4 | $61.1K | Hold |
3,680
| – | – | ﹤0.01% | 1296 |
|
|
2023
Q3 | $68.7K | Hold |
3,680
| – | – | ﹤0.01% | 1270 |
|
|
2023
Q2 | $89.3K | Hold |
3,680
| – | – | ﹤0.01% | 1274 |
|
|
2023
Q1 | $80.4K | Sell |
3,680
-800
| -18% | -$17.5K | ﹤0.01% | 1268 |
|
|
2022
Q4 | $107K | Buy |
4,480
+1,320
| +42% | +$31.4K | ﹤0.01% | 1205 |
|
|
2022
Q3 | $87K | Buy |
3,160
+880
| +39% | +$24.2K | ﹤0.01% | 1299 |
|
|
2022
Q2 | $69K | Buy |
+2,280
| New | +$69K | ﹤0.01% | 1259 |
|